EUVIMEDEUVIMED entdecken
Multizentrische Studie

A multicenter prospective evaluation of the benefits of Dexcom ONE + in subjects with type 2 diabetes on insulin therapy beyond glycemic control: results from the LIFE-ONE study

Ana Chico, Eva Aguilera-Hurtado, Mercè Albareda, Jesús Moreno-Fernández, Pilar Beato-Vibora, Elsa Fernández-Rubio, Martín Cuesta, Amparo Bartual, Francisco Javier Ampudia-Blasco, Orosia Bandrés, Jessica Ares, María Teresa Rivero und 1 weitere

Acta Diabetologica · 11.04.2026 · 63 (6) · 1057-1066

DOI: 10.1007/s00592-026-02682-9 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Acta Diabetologica, online erschienen am 11.04.2026. Verfasst von Ana Chico und 12 weiteren Autor:innen. Beteiligte Einrichtung: Endocrinology and Nutrition Department, Hospital Santa Creu i Sant Pau Barcelona, Spain. C/San Quintín 167, 08025, Barcelona, Spain. achicob@santpau.…. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Insulin, Hypoglycemic Agents. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 34 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, Type 2InsulinHypoglycemic AgentsHumansFemaleMiddle AgedMaleContinuous Glucose MonitoringProspective StudiesGlycemic ControlBlood GlucoseQuality of LifeGlycated HemoglobinAgedHypoglycemiaTreatment Outcome

Stichwörter der Autor:innen

Continuous glucose monitoringDexcomGlucometric dataInsulinPatient-reported outcomesType 2 diabetes

Substanzen

InsulinHypoglycemic AgentsBlood GlucoseGlycated Hemoglobin

Autor:innen und Institutionen

  • Endocrinology and Nutrition Department, Hospital Santa Creu i Sant Pau Barcelona, Spain. C/San Quintín 167, 08025, Barcelona, Spain. achicob@santpau.cat.
  • Institut de Recerca Sant Pau (IR SANT PAU), Barcelona, Spain. achicob@santpau.cat.
  • Universitat Autònoma de Barcelona, Barcelona, Spain. achicob@santpau.cat.
  • CIBER-BBN, Instituto de Salud Carlos III, Madrid, Spain. achicob@santpau.cat.
  • Endocrinology and Nutrition Department, Germans Trias i Pujol University Hospital, Badalona, Spain.
  • Endocrinology and Nutrition Department, Complex Hospitalari Universitari Moisès Broggi, Sant Joan Despí, Barcelona, Spain.

Zitieren

APA

Chico, A., Aguilera-Hurtado, E., Albareda, M., Moreno-Fernández, J., Beato-Vibora, P., Fernández-Rubio, E., Cuesta, M., Bartual, A., Ampudia-Blasco, F. J., Bandrés, O., Ares, J., Rivero, M. T., & Picón-César, M. J. (2026). A multicenter prospective evaluation of the benefits of Dexcom ONE + in subjects with type 2 diabetes on insulin therapy beyond glycemic control: results from the LIFE-ONE study. Acta Diabetologica, 63(6), 1057-1066. https://doi.org/10.1007/s00592-026-02682-9

Vancouver

Chico A, Aguilera-Hurtado E, Albareda M, Moreno-Fernández J, Beato-Vibora P, Fernández-Rubio E, et al. A multicenter prospective evaluation of the benefits of Dexcom ONE + in subjects with type 2 diabetes on insulin therapy beyond glycemic control: results from the LIFE-ONE study. Acta Diabetologica. 2026;63(6):1057-1066. doi:10.1007/s00592-026-02682-9

BibTeX
@article{Chico2026,
  author = {Chico, Ana and Aguilera-Hurtado, Eva and Albareda, Mercè and Moreno-Fernández, Jesús and Beato-Vibora, Pilar and Fernández-Rubio, Elsa and Cuesta, Martín and Bartual, Amparo and Ampudia-Blasco, Francisco Javier and Bandrés, Orosia and Ares, Jessica and Rivero, María Teresa and Picón-César, María José},
  title = {A multicenter prospective evaluation of the benefits of Dexcom ONE + in subjects with type 2 diabetes on insulin therapy beyond glycemic control: results from the LIFE-ONE study},
  journal = {Acta Diabetologica},
  year = {2026},
  volume = {63},
  number = {6},
  pages = {1057--1066},
  doi = {10.1007/s00592-026-02682-9}
}
Kostenlos starten →